Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Compliance With Once Daily Glaucoma Medication

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT00333463
First received: June 1, 2006
Last updated: April 7, 2012
Last verified: March 2010
  Purpose

A study to examine patient compliance with once daily glaucoma medication


Condition Intervention
Compliance
Behavioral: Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Compliance With Once Daily Glaucoma Medication

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Estimated Enrollment: 700
Study Start Date: June 2006
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
No Intervention: Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00333463

Locations
United States, Texas
Ft. Worth
Ft. Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Johns Hopkins University
University of Pennsylvania
Investigators
Study Director: David Friedman, MD Study Director
  More Information

No publications provided

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00333463     History of Changes
Other Study ID Numbers: CMS-06-03
Study First Received: June 1, 2006
Last Updated: April 7, 2012
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on November 20, 2014